Results for this period
Interim period (second quarter)1 April 2026 to 30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Higher sales of products and solutions, lower cost of sales, higher selling, general and administrative expenses including R&D, research and personnel expenses, higher dividend income, and recognition of a gain on the sale of investment securities
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 September 2026 |
| Net Sales | ¥869 million (YoY +0.8%) |
| Operating profit | ¥315 million (YoY -2.1%) |
| Ordinary income | ¥361 million (YoY +3.3%) |
| Profit attributable to owners of the parent | ¥282 million (YoY +26.4%) |
| Net income per share | ¥80.12 |
| Equity ratio | End of the current fiscal period 82.5 / End of previous period 82.5 |
| Total assets | ¥5,205 million |
| Net assets | ¥4,295 million |
| Cash flows from operating activities | ¥282,061 thousand |
| Cash flows from investing activities | ¥-103,967 thousand |
| Cash flows from financing activities | ¥-133,591 thousand |
| Cash and cash equivalents at end of period | ¥931,911 thousand |
| Full-year earnings forecast | Net Sales ¥1,770 million (YoY +2.1%) / Operating profit ¥619 million (YoY +2.5%) / Ordinary income ¥664 million (YoY +3.9%) / Net income ¥465 million (YoY +56.6%) |
| Annual Dividend Forecast | 38 Yen → 38 Yen（0.0%） |
| Depreciation and amortization | ¥37,934 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥61,016 thousand / Extraordinary loss Not disclosed |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies / Excluded 0 companies / Company name Not applicable |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | Yes (target audience: Not disclosed) |
| Issued Shares at Period-End | 3,570,000 shares |
| Treasury Shares at Period-End | 41,914 shares |
| Factors Behind Changes in Business Performance | Higher sales of products and solutions, lower cost of sales, higher selling, general and administrative expenses including R&D, research and personnel expenses, higher dividend income, and recognition of a gain on the sale of investment securities |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue increased, driven by higher sales of products and solutions such as the Vehicle Model Database, RV Doctor and PV Doctor, although sales of CA Doctor fell below the year-earlier period. Operating profit declined because, despite a 2.7% year-on-year decrease in cost of sales, selling, general and administrative expenses, including R&D, research and personnel expenses, increased 5.0%. The increase in ordinary profit was attributed to higher dividend income and other factors, while the increase in interim net income attributable to owners of the parent was attributed to the recognition of a gain on the sale of investment securities.